LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 47 filers reported holding LOGICBIO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $34,000 | -89.1% | 50,285 | -62.8% | 0.00% | – |
Q4 2021 | $312,000 | +40.5% | 135,027 | +178.1% | 0.00% | – |
Q3 2021 | $222,000 | -47.0% | 48,559 | -48.5% | 0.00% | – |
Q2 2021 | $419,000 | -7.1% | 94,314 | +59.5% | 0.00% | – |
Q4 2020 | $451,000 | +219.9% | 59,132 | +279.6% | 0.00% | – |
Q3 2020 | $141,000 | – | 15,578 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 8,466,783 | $5,758,000 | 0.09% |
HARBOR CAPITAL ADVISORS, INC. | 226,731 | $154,000 | 0.07% |
Sio Capital Management, LLC | 182,630 | $124,000 | 0.04% |
Virtu Financial LLC | 71,475 | $49,000 | 0.00% |
Independence Bank of Kentucky | 10,200 | $7,000 | 0.00% |
SANDERS MORRIS HARRIS LLC | 15,000 | $10,000 | 0.00% |
Endurance Wealth Management, Inc. | 1,500 | $12,000 | 0.00% |
Baker Brothers Advisors | 451,478 | $307,000 | 0.00% |
Texas Yale Capital Corp. | 20,000 | $14,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 79,900 | $54,000 | 0.00% |